.75 semaglutide Obesity drug Wegovy reduces cardiovascular risks for those at high risk It is used in combination with a reduced calorie diet and increased physical activity A secret shopper study found

Wegovy is a 'name-brand' form of semaglutide, a type of medication called a glucagon-like peptide 1 receptor agonist, better known as a GLP-1. Semaglutide the active ingredient in Wegovy works by mimicking the GLP-1 hormones that are naturally secreted by the intestine after a meal

These medications have been shown to suppress appetite, slow gastric emptying, and improve insulin sensitivity, making them a powerful tool in the fight against obesity

The G6PD Deficiency GenoArray Diagnostic Kit (Hybribio, Sheung Wan, Hong Kong, China) is an all-in-one integrated polymerase chain reaction (PCR), hybridization, and gene chip processing system based on flow-through hybridization technology which can provide a rapid and accurate nucleic acid analysis of a patient sample

Null hypothesis considered for this statistical test assumed that the TSPD would be same for CU and LoS in an airway model

Natural products derived from plants have shown promising results in thyroid cancer treatment

Methaemoglobinaemia can complicate normothermic machine perfusion of human livers